{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["46"],"submitter":["Seo Y"],"funding":["Korea Disease Control and Prevention Agency"],"pubmed_abstract":["<h4>Objectives</h4>Cardiovascular diseases are a leading cause of mortality worldwide, and acute myocardial infarction (AMI) is particularly fatal condition. We evaluated the incidence and case fatality rates of AMI in Korea from 2011 to 2020.<h4>Methods</h4>We utilized data from the National Health Insurance Services to calculate crude, age-standardized, and age-specific incidence rates, along with 30-day and 1-year case fatality rates, of AMI from 2011 to 2020. Age-standardized incidence rates were determined using direct standardization to the 2005 population.<h4>Results</h4>The crude incidence rate of AMI per 100,000 person-years consistently increased from 44.7 in 2011 to 68.3 in 2019, before decreasing slightly to 66.2 in 2020. The age-standardized incidence rate of AMI displayed a 19% rise from 2011 to 2019, followed by a slight decline in 2020. The increasing trend for AMI incidence was more pronounced in males than in females. Both 30-day and 1-year case fatality rates remained stable among younger individuals but showed a decrease among older individuals. There was a minor surge in case fatality in 2020, particularly among recurrent AMI cases.<h4>Conclusions</h4>Over the past decade, the AMI incidence rate in Korea has consistently increased, with a slight downturn in 2020. The case fatality rate has remained relatively stable except for a minor increase in 2020. This study provides data for continuous surveillance, the implementation of targeted interventions, and the advancement of research aimed at AMI in Korea."],"journal":["Epidemiology and health"],"pagination":["e2024002"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10928467"],"repository":["biostudies-literature"],"pubmed_title":["Incidence and case fatality of acute myocardial infarction in Korea, 2011-2020."],"pmcid":["PMC10928467"],"pubmed_authors":["Shin S","Bae JW","Lee SJ","Kim E","Seo Y","Lee HH","Kim HC","Lee H","Kaneko F","Moon J","Kim M","Kim BK"],"additional_accession":[]},"is_claimable":false,"name":"Incidence and case fatality of acute myocardial infarction in Korea, 2011-2020.","description":"<h4>Objectives</h4>Cardiovascular diseases are a leading cause of mortality worldwide, and acute myocardial infarction (AMI) is particularly fatal condition. We evaluated the incidence and case fatality rates of AMI in Korea from 2011 to 2020.<h4>Methods</h4>We utilized data from the National Health Insurance Services to calculate crude, age-standardized, and age-specific incidence rates, along with 30-day and 1-year case fatality rates, of AMI from 2011 to 2020. Age-standardized incidence rates were determined using direct standardization to the 2005 population.<h4>Results</h4>The crude incidence rate of AMI per 100,000 person-years consistently increased from 44.7 in 2011 to 68.3 in 2019, before decreasing slightly to 66.2 in 2020. The age-standardized incidence rate of AMI displayed a 19% rise from 2011 to 2019, followed by a slight decline in 2020. The increasing trend for AMI incidence was more pronounced in males than in females. Both 30-day and 1-year case fatality rates remained stable among younger individuals but showed a decrease among older individuals. There was a minor surge in case fatality in 2020, particularly among recurrent AMI cases.<h4>Conclusions</h4>Over the past decade, the AMI incidence rate in Korea has consistently increased, with a slight downturn in 2020. The case fatality rate has remained relatively stable except for a minor increase in 2020. This study provides data for continuous surveillance, the implementation of targeted interventions, and the advancement of research aimed at AMI in Korea.","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024","modification":"2026-06-25T03:13:57.273Z","creation":"2025-04-04T21:31:02.02Z"},"accession":"S-EPMC10928467","cross_references":{"pubmed":["38186244"],"doi":["10.4178/epih.e2024002"]}}